Prevalence of the Condition Anticipated to Push the Global Brain Aneurysm Treatment Market

Brain aneurysm is an abnormal bulge in the blood vessels of the brain that can go on to cause severe health-based issues and        possible even death. It causes the inner muscular layer of the blood vessel wall to weaken. After a prolonged period of time, the blood flow within the artery keeps pushing the thin wall portion and eventually ends-up rupturing it. The bleeding caused due to the ruptured brain artery is known as subarachnoid hemorrhage (SAH).

Global Brain Aneurysm Treatment Market Expected to Grow at a CAGR of 5.4% During the Forecast Period with Industry Analysis, Size, Share, Growth, Trends and Forecast 2019 - 2023

Ask for free sample@ https://www.marketresearchfuture.com/sample_request/4561

The hemorrhage is so severe that it can lead to stroke, coma, or even death. Various factors contribute to its occurrence, including injury or trauma, cigarette smoking, blood infections, and others. Individuals suffering from this condition of brain aneurysm can be diagnoses through multiple means or techniques, including cerebral angiogram, Computed Tomography (CT) scan, Magnetic Resonance Angiography (MRA), Computed Tomography Angiogram (CTA) scan, and many others.

Market Research Future (MRFR) asserts in its report that the global market is influenced by various key factors. This includes, the increasing and widespread prevalence of brain aneurysms, rising occurrence of high blood pressure, rapid advancements in surgical techniques, and increasing funding by the government and related bodies in the healthcare sector. Also, the presence of brain aneurysm in the family is another key driver of the market.

However, issues like high management cost of aneurysmal subarachnoid hemorrhage and unknown symptoms of unruptured brain aneurysm can hamper the overall growth of the market.

Competitive Landscape

The global brain aneurysm treatment market includes a number of key players, including Orsan Medical Technologies, Head Sense Medical, InfraScan, Inc., MicroPort Scientific Corporation, Raumedic AG, HaiWeiKang, Johnson & Johnson, Spiegelberg GmbH, Vittamed, and others.

April 2nd, 2019, an all-new and approved treatment device to fight against brain aneurysms was available in Toledo. With an estimated 6 million people in the United States suffering from unruptured brain aneurysms, this development will be of great advantage.

April 16th, 2019, Stryker, a medical technology company, announced the introduction of the next generation Surpass Evolve Flow Diverter to treat and cure brain aneurysms.

Market Segmentation

The brain aneurysm treatment market segmentation is based in terms of condition, type, and end-user.

By type, the market divides into medication and surgery.

The surgery segment narrows down further into endovascular coiling, surgical clipping, flow diverter, and others. The flow diverter segment breaks down into silk flow diverter (SILK), pipeline embolization device, and surpass flow diverter (SURPASS).

The medication segment comprises calcium channel blockers, anti-seizure medications, antacids, antiemetics, analgesics, antihypertensives, stool softeners, and others.

By end-user, the market includes clinics, hospital, and others.

By condition, the market divides into ruptured and unruptured aneurysm.

BROWSE COMPLETE 100 PAGES PREMIUM RESEARCH REPORT ENABLED WITH 40+ RESPECTIVE TABLES AND FIGURES @ https://www.marketresearchfuture.com/reports/brain-aneurysm-treatment-market-4561